Nirvana Life Sciences Inc. (CSE: NIRV)
Canada
· Delayed Price · Currency is CAD 0.0750
0.00 (0.00%)
Nov 22, 2024, 4:00 PM EST
Nirvana Life Sciences Company Description
Nirvana Life Sciences Inc. engages in the scientific research and development of therapeutic products derived from psychedelics.
It also focuses on developing methodologies for extraction and purification of psychoactive compounds.
The company is headquartered in Vancouver, Canada.
Nirvana Life Sciences Inc.
| Country | Canada |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Bruce Clark |
Contact Details
Address: 650 West Georgia Street Vancouver, British Columbia V6B 4N8 Canada | |
| Phone | 604-401-8100 |
| Website | nirvanalifescience.com |
Stock Details
| Ticker Symbol | NIRV |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | May - April |
| Reporting Currency | CAD |
| ISIN Number | CA6546521064 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Bruce Clark | Chief Executive Officer and Director |
| Patricia Ann Storey B.B.A., BBA, C.A., CA, CPA | Chief Financial Officer and Director |
| Michael McCune | Vice President of Operations |
| Dr. Sazzad Hossain M.Sc., Ph.D. | Chief Scientific Officer |
| Robert August IV, M.Sc. | Head of Innovation |
| Dr. Massimo Nabissi Ph.D. | Head of Clinical Trials |